Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function

被引:58
作者
Bavenholm, P [1 ]
de Faire, U
Landou, C
Efendic, S
Nilsson, J
Wiman, B
Hamsten, A
机构
[1] Karolinska Hosp, Dept Emergency & Cardiovasc Med, Div Internal Med, S-17176 Stockholm, Sweden
[2] Karolinska Hosp, Dept Thorac Radiol, S-17176 Stockholm, Sweden
[3] Karolinska Hosp, Dept Endocrinol, S-17176 Stockholm, Sweden
[4] Karolinska Hosp, Dept Clin Chem & Blood Coagulat, S-17176 Stockholm, Sweden
[5] Karolinska Inst, King Gustaf V Res Inst, Atherosclerosis Res Unit, Stockholm, Sweden
关键词
lipoproteins; plasminogen activator inhibitor-1; glucose; insulin; myocardial infarction; coronary angiography;
D O I
10.1053/euhj.1997.0752
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To assess determinants of coronary artery disease progression in men with previous myocardial infarction. Methods and Results A total of 102 unselected nondiabetic Swedish men (age 40.4+/-3.6, range 23-44 years) entered the study 3-6 months after a first myocardial infarction. The programme included metabolic and haemostatic investigations and routine coronary angiography at baseline, followed by re-angiography 5 years later. Of the original cohort, 76 patients underwent a second angiogram. Separate semiquantitative scoring systems were used for diffuse coronary atherosclerosis and distinct stenoses in 15 proximal coronary segments. Smoking, global severity of coronary atherosclerosis and presence of multi-vessel disease at baseline (P<0.001) characterized patients with severe progression of both diffuse and focal lesions. Higher plasma levels of low density lipoprotein cholesterol (P<0.01) and low density lipoprotein triglycerides (P<0.05), a lower plasma high density lipoprotein, cholesterol level (P<0.05) and higher plasma plasminogen activator inhibitor-1 activity (P<0.05), together with a high baseline stenosis score (P<0.001) characterized patients with severe progression of coronary atherosclerosis. On the other hand, more pronounced fasting and post-prandial glycaemia (P<0.05), together with higher plasma plasminogen activator inhibitor-1 activity (P<0.01) characterized severe progressors with respect to coronary stenosis. Multivariate analysis identified the presence of multi-vessel disease as an independent predictor of progression of both coronary atherosclerosis (P=0.008) and stenoses (P=0.007), whereas a high low density lipoprotein triglyceride level (P<0.01) was independently related to progression of coronary atherosclerosis and a high fasting glucose level (P=0.02) to progression of coronary stenoses. Conclusion Disturbances in carbohydrate and lipoprotein metabolism and impaired fibrinolytic function are associated with progression of coronary artery disease in young male post-infarction patients.
引用
收藏
页码:402 / 410
页数:9
相关论文
共 47 条
  • [1] Austen W. G., 1975, CIRCULATION, V51, P7
  • [2] AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
  • [3] ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK
    AUSTIN, MA
    KING, MC
    VRANIZAN, KM
    KRAUSS, RM
    [J]. CIRCULATION, 1990, 82 (02) : 495 - 506
  • [4] PLASMA TRIGLYCERIDE AND CORONARY HEART-DISEASE
    AUSTIN, MA
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 2 - 14
  • [5] INSULIN, INTACT AND SPLIT PROINSULIN, AND CORONARY-ARTERY DISEASE IN YOUNG MEN
    BAVENHOLM, P
    PROUDLER, A
    TORNVALL, P
    GODSLAND, I
    LANDOU, C
    DEFAIRE, U
    HAMSTEN, A
    [J]. CIRCULATION, 1995, 92 (06) : 1422 - 1429
  • [6] ASSOCIATION OF INSULIN AND INSULIN PROPEPTIDES WITH AN ATHEROGENIC LIPOPROTEIN PHENOTYPE
    BAVENHOLM, P
    KARPE, F
    PROUDLER, A
    TORNVALL, P
    CROOK, D
    HAMSTEN, A
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (11): : 1481 - 1488
  • [7] BAVENHOLM P, 1995, THROMB HAEMOSTASIS, V73, P568
  • [8] BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
  • [9] PREDICTION OF ANGIOGRAPHIC CHANGE IN NATIVE HUMAN CORONARY-ARTERIES AND AORTOCORONARY BYPASS GRAFTS - LIPID AND NONLIPID FACTORS
    BLANKENHORN, DH
    ALAUPOVIC, P
    WICKHAM, E
    CHIN, HP
    AZEN, SP
    [J]. CIRCULATION, 1990, 81 (02) : 470 - 476
  • [10] Carlson K, 1973, J Clin Pathol Suppl (Assoc Clin Pathol), V5, P32